Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer

O Abulkhair, M Al Balwi, O Makram… - Journal of Global …, 2018 - ascopubs.org
Purpose Over the past three decades, the incidence rate of breast cancer (BC) among Arab
women has continually increased. However, data on the prevalence of BRCA1/2 mutations …

[PDF][PDF] Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer

O Abulkhair, M Al Balwi - 2018 - pdfs.semanticscholar.org
Purpose Over the past three decades, the incidence rate of breast cancer (BC) among Arab
women has continually increased. However, data on the prevalence of BRCA1/2 mutations …

Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer

O Abulkhair, M Al Balwi, O Makram… - Journal of global …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose Over the past three decades, the incidence rate of breast cancer (BC) among Arab
women has continually increased. However, data on the prevalence of BRCA1/2 mutations …

Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer.

O Abulkhair, M Al Balwi, O Makram… - Journal of Global …, 2018 - europepmc.org
Purpose Over the past three decades, the incidence rate of breast cancer (BC) among Arab
women has continually increased. However, data on the prevalence of BRCA1/2 mutations …

Prevalence of BRCA1 and BRCA2 mutations among high-risk Saudi patients with breast cancer

O Abulkhair, M Al Balwi… - Journal of …, 2018 - mdanderson.elsevierpure.com
Purpose Over the past three decades, the incidence rate of breast cancer (BC) among Arab
women has continually increased. However, data on the prevalence of BRCA1/2 mutations …

[HTML][HTML] Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer

O Abulkhair, M Al Balwi, O Makram… - Journal of Global …, 2018 - ncbi.nlm.nih.gov
Purpose Over the past three decades, the incidence rate of breast cancer (BC) among Arab
women has continually increased. However, data on the prevalence of BRCA1/2 mutations …